Ethnic and Gender Disparities in Access to Deep Brain Stimulation for Parkinson’s Disease Among Participants in C-OPN
Objective: To study the disparities in gender and ethnicity and the related contributing factors in Parkinson’s disease (PD) patients who require deep brain stimulation (DBS),…Progression of the Clinical Features of Progressive Supranuclear Palsy-Richardson Syndrome in Early and Advanced Stages
Objective: We sought to evaluate PSP-Richardson syndrome (PSP-RS) for uniformity of progression over nearly the entire disease course. Rather than comparing scores to the simple…Comparative Assessment of Gait and Balance in Patients with Parkinson’s Disease and Normal Pressure Hydrocephalus
Objective: Parkinson's disease (PD) and normal pressure hydrocephalus (NPH) cause gait and balance problems, which often lead to falls. The mechanisms responsible for gait and…Gene-environment interactions for Parkinson’s disease
Objective: The aim of this study was to test for interactions between PD-related genetic and phenotypic traits in the 23andMe, Inc. research cohort. Background: Parkinson’s…The value of volume of the subthalamic nucleus in diagnosis of progressive supranuclear palsy
Objective: To investigate the diagnostic accuracy of STN volume in PSP using quantitative susceptibility mapping (QSM) imaging and 3T MRI. Background: Various MRI markers are…Pilot study incorporating outcome measures after paediatric deep brain stimulation with patient and carer expectations and satisfaction
Objective: To pilot a multi-faceted evaluation framework for paediatric patients undergoing deep brain stimulation (DBS) in a single centre. Background: DBS can be useful for…A Phase 2, Double-blinded, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of ABP-450 (PrabotulinumtoxinA) in Adults with Isolated Cervical Dystonia
Objective: To evaluate the safety and the efficacy of ABP-450 (prabotulinumtoxinA) in patients with cervical dystonia (CD). Background: ABP-450 (prabotulinumtoxinA) is a new 900kDA botulinumtoxinA.…Stability and predictability of motor symptom control in patients with advanced Parkinson’s disease (aPD) receiving continuous subcutaneous foslevodopa/foscarbidopa (LDP/CDP)
Objective: To evaluate temporal changes in motor states (OFF and ON without troublesome dyskinesia [TD; good ON]) throughout the waking day in patients with aPD…Relationship between sleep quality, fear of fall and falls history in people with Parkinson’s disease
Objective: We aimed to investigate the relationship of sleep quality with falls and fear of fall (FOF) in people with Parkinson's disease (PwPD). Background: Fall…Honey prevented MPTP-induced oxidative stress, neuroinflammation and gliosis in adult male Swiss mice.
Objective: To investigate the neuroprotective role of honey against oxidative stress and neuroinflammation induced by MPTP in adult male Swiss mice. Background: Oxidative stress and…
- « Previous Page
- 1
- …
- 273
- 274
- 275
- 276
- 277
- …
- 1554
- Next Page »